A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol: a Double Blind Randomized Controlled Study
Phase of Trial: Phase IV
Latest Information Update: 17 Feb 2015
At a glance
- Drugs Remifentanil (Primary) ; Esmolol
- Indications Hypertension; Tachycardia
- Focus Therapeutic Use
- Acronyms Dilek Esmolol
- 30 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 17 Dec 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov record.
- 03 Jul 2012 New trial record